Coty Inc.: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 9, 2022 and accepted by EDGAR at May 9, 2022, 16:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $1.19bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-07-01 to 2022-03-31 | $4.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $423.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-07-01 to 2022-03-31 | $1.49bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $763.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-07-01 to 2022-03-31 | $2.65bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $659.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-07-01 to 2022-03-31 | $2.15bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $57.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-07-01 to 2022-03-31 | $318.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $60.9m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-07-01 to 2022-03-31 | $185.4m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $500.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-07-01 to 2022-03-31 | $164.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $53.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-07-01 to 2022-03-31 | $541.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-07-01 to 2022-03-31 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-07-01 to 2022-03-31 | $0.42 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 852,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-07-01 to 2022-03-31 | 827,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-07-01 to 2022-03-31 | $759.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-07-01 to 2022-03-31 | $133.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2021-07-01 to 2022-03-31 | $1.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2022-03-31 | $668.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $2.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $13.27bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $3.20bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $9.26bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $4.32bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $516.5m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2022-03-31 | $4.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-03-31 | $3.60bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-22-000028. Last ingested by Listed: Nov 5, 2026, 18:58 ET. Listed shows no prices and gives no investment advice.